Arctic Bioscience Logo

Arctic Bioscience

Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arctic Bioscience is a biotechnology company that develops, manufactures, and commercializes pharmaceutical and nutraceutical ingredients derived from marine membrane lipids. Leveraging over 30 years of experience, the company utilizes proprietary technology to extract bioactive compounds, such as high-DHA Omega-3 phospholipids, from sustainably sourced Norwegian herring roe. Its business is structured into two main segments: a nutraceutical division, which markets products under the Romega® brand, and a pharmaceutical division focused on developing novel therapies for autoimmune disorders. The company's approach is founded on extensive scientific research and a commitment to sustainable practices.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Arctic Bioscience and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 08:00
Investor Presentation
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
English 3.7 MB
2025-08-28 08:00
Investor Presentation
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Pre…
English 3.7 MB
2025-08-28 08:00
Interim Report
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
English 457.5 KB
2025-08-28 08:00
Interim Report
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Hal…
English 457.5 KB
2025-08-28 08:00
Earnings Release
Arctic Bioscience - Stable development with upside potential
English 7.6 KB
2025-08-28 08:00
Earnings Release
Arctic Bioscience - Stabil utvikling med oppsidepotensial
Norwegian 7.8 KB
2025-08-21 12:19
Report Publication Announcement
Arctic Bioscience - Invitation to presentation of half year 2025 results
English 2.3 KB
2025-08-21 12:19
Report Publication Announcement
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2025
Norwegian 2.2 KB
2025-08-18 10:28
Regulatory News Service
Arctic Bioscience - Signifikant synsforbedring i klinisk grønn stær-studie
Norwegian 2.6 KB
2025-08-18 10:28
Regulatory News Service
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucom…
English 2.6 KB
2025-08-12 13:46
Regulatory News Service
Arctic Bioscience lanserer nytt hudpleieprodukt - Romega Skin Refine
Norwegian 3.3 KB
2025-08-12 13:46
Regulatory News Service
Arctic Bioscience launches new skin care product - Romega Skin Refine
English 3.3 KB
2025-07-01 17:00
Investor Presentation
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
English 3.9 MB
2025-07-01 17:00
Investor Presentation
Arctic Bioscience - 12-måneders data bekrefter potensialet for HRO350 i mild ti…
English 3.9 MB
2025-07-01 17:00
Regulatory News Service
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
English 3.9 KB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan 4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark STENO
Sumitomo Pharma Co., Ltd. Logo
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan 4506
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan 4582
SynAct Pharma Logo
Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.
Sweden SYNACT
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.
Poland SNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.